Periosteal Chondrosarcoma: a Single Institution Experience

Plain-language summary

This study retrospectively reviews a single institution's experience with patients diagnosed with periosteal chondrosarcoma (a bone tumor). It included patients treated at the Rizzoli Institute who had a diagnosis of periosteal chondrosarcoma. It was a study without a phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Istituto Ortopedico Rizzoli

Start date

4/1/2020

Estimated completion

9/30/2021

Countries

Italy

Related genes

Locations

• Bologna, Italy

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Male and female patients treated at Rizzoli Institute from 01 Jan 1900 to 31 Dec 2019
* Diagnosis of peristeal chondrosarcoma
* Written informed consent prior to any study-specific analysis and/or data collection

Exclusion Criteria:

* Patients with histological diagnosis different from periosteal chondrosarcoma.